ViruSure
ViruSure GmbH specializes in pathogen safety testing, offering a comprehensive range of services including virus and prion clearance studies, biosafety assessments, genetic stability testing, and GMP cell and virus banking. The company supports biopharmaceutical, vaccine, and cell therapy industries by providing high-quality, GMP-compliant testing and characterization services to ensure the safety, stability, and regulatory compliance of biological products. With extensive experience and advanced facilities, ViruSure is a trusted partner for biopharmaceutical development and manufacturing, dedicated to advancing biosafety and quality in biologics production.
Industries
Nr. of Employees
small (1-50)
Services
Analytical testing of cell and virus banks for stable maintenance and identity of genetic inserts via copy-number assays and sequencing.
Range of validated qPCR assays for virus, mycoplasma, mycobacteria, identity testing and residual DNA quantitation; sequencing services for insert verification.
NGS-based metagenomic workflows for broad contaminant detection and quality-control testing of biologics.
GMP production and documentation for Master and Working Cell/Virus Banks and Extended/End-of-Production banks to serve as regulated starting material.
Monitored GMP storage options (freezer, cryo-freezer, liquid-nitrogen vapor) with continuous temperature monitoring and alarmed emergency systems.
Comprehensive test packages for identity, purity, adventitious agents, retrovirus assays and other characterization required for bank release.
Analytical testing of cell and virus banks for stable maintenance and identity of genetic inserts via copy-number assays and sequencing.
Range of validated qPCR assays for virus, mycoplasma, mycobacteria, identity testing and residual DNA quantitation; sequencing services for insert verification.
NGS-based metagenomic workflows for broad contaminant detection and quality-control testing of biologics.
GMP production and documentation for Master and Working Cell/Virus Banks and Extended/End-of-Production banks to serve as regulated starting material.
Monitored GMP storage options (freezer, cryo-freezer, liquid-nitrogen vapor) with continuous temperature monitoring and alarmed emergency systems.
Comprehensive test packages for identity, purity, adventitious agents, retrovirus assays and other characterization required for bank release.
Expertise Areas
- Pathogen safety testing for biologics
- GMP cell and virus banking and storage
- Viral and prion clearance study design and execution
- Molecular assay development and qPCR-based diagnostics
Key Technologies
- Quantitative PCR (qPCR)
- Sanger sequencing
- Next-generation sequencing (metagenomics)
- Fluorescent product-enhanced RT assay (PERT)
News & Updates
ViruSure GmbH collaborates with neotem Bioanalytics, experts in Electron Microcopy Analysis.
ViruSure held its 2nd Virus Safety Workshop in Vienna, focusing on biosafety and virus detection.
ViruSure expands its NGS capabilities with Oxford Nanopore certification.
ViruSure GmbH welcomes Bionova Scientific, its new sister company in the USA.
ViruSure expands its Next Generation Sequencing capabilities using Oxford Nanopore’s MinION device.
Partnership announcement between ViruSure and Bionique, supported by Asahi Kasei Medical.
ViruSure GmbH collaborates with neotem Bioanalytics, experts in Electron Microcopy Analysis.
ViruSure held its 2nd Virus Safety Workshop in Vienna, focusing on biosafety and virus detection.
ViruSure expands its NGS capabilities with Oxford Nanopore certification.
ViruSure GmbH welcomes Bionova Scientific, its new sister company in the USA.
ViruSure expands its Next Generation Sequencing capabilities using Oxford Nanopore’s MinION device.
Partnership announcement between ViruSure and Bionique, supported by Asahi Kasei Medical.